Jason G. Duncan's Insider Trades & SAST Disclosures

Jason G. Duncan's most recent trade in Neumora Therapeutics Inc. was a trade of 750,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 8, 2026.

Share

Note

This is a custom search result for pattern Jason G. Duncan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Neumora Therapeutics Inc	Jason G. Duncan	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jan 2026	750,000	750,000	-		-	Stock Option (Right to Buy)
Neumora Therapeutics Inc	Jason G. Duncan	See Remarks	Sale or transfer of securities back to the company at price $ 0.00 per share.	28 May 2025	500,000	0	-		-	Stock Option (Right to Buy)
Neumora Therapeutics Inc	Jason G. Duncan	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 May 2025	500,000	500,000	-		-	Stock Option (Right to Buy)
Neumora Therapeutics Inc	Jason G. Duncan	See Remarks	Sale or transfer of securities back to the company at price $ 0.00 per share.	28 May 2025	400,000	0	-		-	Stock Option (Right to Buy)
Neumora Therapeutics Inc	Jason G. Duncan	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 May 2025	400,000	400,000	-		-	Stock Option (Right to Buy)
Neumora Therapeutics Inc	Jason G. Duncan	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2025	500,000	500,000	-		-	Stock Option (Right to Buy)
Neumora Therapeutics Inc	Jason G. Duncan	See Remarks	Sale or transfer of securities back to the company at price $ 0.00 per share.	13 Feb 2025	400,000	0	-		-	Stock Option (Right to Buy)
Neumora Therapeutics Inc	Jason G. Duncan	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2025	400,000	400,000	-		-	Stock Option (Right to Buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades